<div><div></div><div>Voyager Acquisition, alongside Veraxa Biotech Holding and Veraxa Biotech, unveiled a financing package tied to their pending deSPAC. The group agreed to a $27.5 million private placement of senior secured notes and warrants, with the notes maturing in August 2027 and warrants covering up to 2,391,305 shares at $11.50. To secure the notes, PubCo will grant first-priority liens over assets and controlled accounts. Separately, the parties established a committed equity purchase facility of up to $50 million with Lincoln Park, supported by registration rights to enable resale, providing flexible post-merger funding.Agreement 1: Voyager Acquisition Raises $27.5M Via Secured Notes and Warrants to Support deSPAC<ul><li>Agreement type: Private placement of senior secured notes and warrants</li><li>Counterparty: Multiple investors</li><li>Signed / Effective: May 27 2026 / same</li><li>Duration / Termination: Notes mature Aug 27 2027</li><li>Reason: Fund deSPAC, working capital and corporate purposes</li></ul>Agreement 2: Voyager Acquisition Grants First-Priority Liens to Secure $27.5M Notes<ul><li>Agreement type: First-priority security and control agreements securing notes</li><li>Counterparty: Collateral agent for noteholders</li><li>Signed / Effective: May 27 2026 / same</li><li>Duration / Termination: Until notes repaid</li><li>Reason: Perfect liens securing note obligations</li></ul>Agreement 3: Voyager Acquisition Secures Up to $50M Equity Purchase Facility With Lincoln Park<ul><li>Agreement type: Committed equity purchase facility up to $50 million</li><li>Counterparty: Lincoln Park Capital Fund</li><li>Signed / Effective: May 27 2026 / Upon post-merger commencement</li><li>Duration / Termination: Up to 24 months after commencement</li><li>Reason: Flexible funding post-merger</li></ul>Agreement 4: Voyager Acquisition Grants Registration Rights to Lincoln Park for Resale<ul><li>Agreement type: Registration rights for resale of shares issued to Lincoln Park</li><li>Counterparty: Lincoln Park Capital Fund</li><li>Signed / Effective: May 27 2026 / same</li><li>Duration / Termination: Until registration maintained as required</li><li>Reason: Enable resale of shares under equity facility</li></ul>Original SEC Filing: Voyager Acquisition Corp./Cayman Islands [ VACH ] - 8-K - May. 29, 2026<section>Disclaimer<div>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</div></section></div></div>

VOYG

VOYX

Voyager Acquisition announced a financing package for its pending deSPAC with Veraxa Biotech. The deal includes a $27.5M private placement of senior secured notes maturing in August 2027, backed by first-priority liens on assets. Additionally, the company secured a committed $50M equity purchase facility with Lincoln Park Capital Fund to provide flexible post-merger funding, accompanied by registration rights for share resale.

TradingView

Voyager Tech

Voyager Acquisition Arranges $27.5M Secured Notes, Warrants and $50M Equity Facility With Lincoln Park